Clinical Trials

Showing trials with last updates posted in 2026.

NCT02978625 | ACTIVE_NOT_RECRUITING | PHASE2
68 participants

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2017-09-27
Completion:
2027-09-01
Conditions
  • Anaplastic Large Cell Lymphoma, ALK-Negative
  • Anaplastic Large Cell Lymphoma, ALK-Positive
  • Apocrine Carcinoma
  • Carcinoma Arising From Cylindroma
  • Carcinoma Arising From Spiradenoma
  • Digital Papillary Adenocarcinoma
  • Endocrine Mucin-Producing Sweat Gland Carcinoma
  • Extramammary Paget Disease
  • Extraocular Sebaceous Carcinoma
  • Hidradenocarcinoma
  • Malignant Sweat Gland Neoplasm
  • Merkel Cell Carcinoma
  • Microcystic Adnexal Carcinoma
  • NK-Cell Lymphoma, Unclassifiable
  • Papillary Adenocarcinoma
  • Porocarcinoma
  • Primary Cutaneous Mucinous Carcinoma
  • Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
  • Recurrent T-Cell Non-Hodgkin Lymphoma
  • Refractory Anaplastic Large Cell Lymphoma
  • Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
  • Refractory Merkel Cell Carcinoma
  • Refractory Mycosis Fungoides
  • Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
  • Refractory Skin Squamous Cell Carcinoma
  • Refractory T-Cell Non-Hodgkin Lymphoma
  • Sezary Syndrome
  • Signet Ring Cell Adenocarcinoma
  • Skin Adenoid Cystic Carcinoma
  • Skin Adnexal Carcinoma
  • Skin Basal Cell Carcinoma
  • Skin Basosquamous Cell Carcinoma
  • Skin Keratoacanthoma
  • Skin Squamous Cell Carcinoma
  • Squamoid Eccrine Ductal Carcinoma
  • Squamous Cell Carcinoma of Unknown Primary
  • Sweat Gland Carcinoma
  • Trichilemmal Carcinoma
  • Vulvar Squamous Cell Carcinoma
Interventions
  • PROCEDURE
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT01728402 | ENROLLING_BY_INVITATION
5000 participants

Pathogenesis of Hematologic Malignancies

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-13
Start Date:
2008-09-30
Conditions
  • Acute Leukemia
  • Lymphoproliferative Disorders
  • Myeloproliferative Disorders
  • Myelodysplastic Syndromes
Interventions
  • PROCEDURE
No Results Yet
NCT01267955 | ACTIVE_NOT_RECRUITING | PHASE2
45 participants

Vismodegib in Treating Patients With Advanced Chondrosarcomas

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2010-12-21
Completion:
2018-06-30
Conditions
  • Clear Cell Chondrosarcoma
  • Dedifferentiated Chondrosarcoma
  • Locally Advanced Chondrosarcoma
  • Mesenchymal Chondrosarcoma
  • Metastatic Chondrosarcoma
  • Primary Central Chondrosarcoma
  • Unresectable Primary Central Chondrosarcoma
Interventions
  • OTHER
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page